CN Patent

CN101360718B — 硫酸氢盐

Assigned to AstraZeneca AB · Expires 2012-01-11 · 14y expired

What this patent protects

本发明涉及化合物1的硫酸氢盐及其溶剂化物、晶体形式和非晶体形式，以及它们的制备方法。

USPTO Abstract

本发明涉及化合物1的硫酸氢盐及其溶剂化物、晶体形式和非晶体形式，以及它们的制备方法。

Drugs covered by this patent

selumetinib-sulfate (SELUMETINIB SULFATE)

Patent Metadata

Patent number: CN101360718B
Jurisdiction: CN
Classification: —
Expires: 2012-01-11
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.